Skip to main content Skip to search Skip to main navigation

Peptide Manufacturer for Research & Developement

JPT Peptide Technologies is a global peptide manufacturer supporting biotechnology and pharmaceutical companies, universities, research institutes and scientific teams with advanced peptide technologies for drug discovery, vaccine development, immunology, proteomics and translational research.


Peptide Manufacturing Capabilities 


Custom Peptide Synthesis


Select your peptide format (pool, library, microarray...), peptide purity (from crude up to >95%) and optional modifications (phosphorylation, biotin, dyes and labeled, cyclization, conjugation, stable-isotope labeling, etc.).


Tailored Synthesis

Scalable Peptide Solutions


Our product range includes micro-scale synthesis (10-50 nmol), intermediate peptide synthesis (1-100 mg), and large-scale peptide synthesis (>1 g).


Tailored Synthesis

Years of Experience


Over the last 20 years, we have developed a unique and very broad expertise in peptide manufacturing and have pioneered patented technologies in the field of peptide libraries, pools and microarrays as well as micro-scale synthesis.


Our Most Popular Products & Services



Our Quality Management

Since 2004, JPT has maintained an active quality management system that is reviewed, audited, and certified annually by an independent certification body (TÜV Rheinland) to ISO 9001:2015 standards.



Research Fields

Cell Therapy & Vaccines

Explore Solutions

Immunology

JPT provides a comprehensive range of peptide-based tools to support clinical immunology research and enable precise investigation of immune mechanisms.
Explore Solutions

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring.
Explore Solutions

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation.
Explore Solutions

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses. 
Explore Solutions
Loading...

Do You Need More Information?

Tailored Synthesis

Speak with a specialist

Reach out to our Customer Support, Sales, or Scientific Assistance teams.

Contact Us

Tailored Synthesis

Check out our FAQs

Browse through the most frequently asked questions about our services.

Browse FAQs

Tailored Synthesis

Explore our Quality & Purity Chart

Explore detailed information on the quality and purity of our products.

See Details

Featured News

Join us at these Conferences & Talks!

This fall, we’re looking forward to meeting researchers, partners, and familiar faces at peptide and life science conferences in North America and Europe.  

  • International Society for Vaccines
  • Immunogenicity and Bioassay Summit
  • Annual Meeting of the French Society for Immunology

etc.

October 2026

Out Now! NEW Protease Substrates!

Studying a protease's activity, requires substrates that are delivered with specificity and reproducibility researchers can rely on. So expand your protease research with new, ready-to-use peptide substrates!  


September 2026

Influenza Research is evolving

Influenza vaccine research has reached an exciting new milestone! FDA approval of an mRNA vaccine for Influenza, marking the first approval of an mRNA flu vaccine in the United States. 


September 2026


Testimonial

Christopher M. Colangelo, Ph.D, Yale University, USA

"As Director of the Protein Profiling at Yale Keck Biotechnology Resource Facility, I coordinated a collaboration between the Association of Biomolecular Resource Facilities (ABRF) standard proteomic research group (sPRG) and JPT Peptide Technologies to develop the ABRF cross-species SpikeMix™ Peptide Pool. The joint development turned out to be an extraordinary effective endeavor and the resulting product was qualified in more than 52 proteomics labs around the globe. I was impressed by JPT's scientific and technological capabilities as well as their enthusiasm to drive the project forward."
See The Products
Loading...

Check our list of products, click and go.

Get a quote